Seysara

Adult Dosing .

Dosage forms:  TAB: 60 mg, 100 mg, 150 mg

acne vulgaris, moderate-severe non-nodular

[33-54 kg]

Dose: 60 mg PO qd; Info: for inflammatory lesions only; give w/ adequate fluids to decr. esophageal irritation/ulceration; reassess tx if no response after 12wk

[55-84 kg]

Dose: 100 mg PO qd; Info: for inflammatory lesions only; give w/ adequate fluids to decr. esophageal irritation/ulceration; reassess tx if no response after 12wk

[85-136 kg]

Dose: 150 mg PO qd; Info: for inflammatory lesions only; give w/ adequate fluids to decr. esophageal irritation/ulceration; reassess tx if no response after 12wk

renal dosing

[see below]

renal impairment: no adjustment; ESRD: not defined

HD/PD: not defined

hepatic dosing

[see below]

Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined

Peds Dosing .

Dosage forms:  TAB: 60 mg, 100 mg, 150 mg

acne vulgaris, moderate-severe non-nodular

[9 yo and older, 33-54 kg]

Dose: 60 mg PO qd; Info: for inflammatory lesions only; give w/ adequate fluids to decr. esophageal irritation/ulceration; reassess tx if no response after 12wk

[9 yo and older, 55-84 kg]

Dose: 100 mg PO qd; Info: for inflammatory lesions only; give w/ adequate fluids to decr. esophageal irritation/ulceration; reassess tx if no response after 12wk

[9 yo and older, 85-136 kg]

Dose: 150 mg PO qd; Info: for inflammatory lesions only; give w/ adequate fluids to decr. esophageal irritation/ulceration; reassess tx if no response after 12wk

renal dosing

[see below]

renal impairment: no adjustment; ESRD: not defined

HD/PD: not defined

hepatic dosing

[see below]

Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined